Matinas BioPharma
MTNB
MTNB
45 hedge funds and large institutions have $18M invested in Matinas BioPharma in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.15% more ownership
Funds ownership: 0.09% → 0.23% (+0.15%)
Holders
45
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.57M | |
| 2 | +$6.43M | |
| 3 | +$1.88M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.79M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.56M |
Top Sellers
| 1 | -$691K | |
| 2 | -$566K | |
| 3 | -$166K | |
| 4 |
Morgan Stanley
New York
|
-$157K |
| 5 |
SIM
Spark Investment Management
New York
|
-$105K |